{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:20:30Z","timestamp":1790533230011,"version":"4.1.0"},"reference-count":200,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Livers"],"abstract":"<jats:p>The epidemic of obesity, type 2 diabetes and nonalcoholic liver disease (NAFLD) favors drug consumption, which augments the risk of adverse events including liver injury. For more than 30 years, a series of experimental and clinical investigations reported or suggested that the common pain reliever acetaminophen (APAP) could be more hepatotoxic in obesity and related metabolic diseases, at least after an overdose. Nonetheless, several investigations did not reproduce these data. This discrepancy might come from the extent of obesity and steatosis, accumulation of specific lipid species, mitochondrial dysfunction and diabetes-related parameters such as ketonemia and hyperglycemia. Among these factors, some of them seem pivotal for the induction of cytochrome P450 2E1 (CYP2E1), which favors the conversion of APAP to the toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI). In contrast, other factors might explain why obesity and NAFLD are not always associated with more frequent or more severe APAP-induced acute hepatotoxicity, such as increased volume of distribution in the body, higher hepatic glucuronidation and reduced CYP3A4 activity. Accordingly, the occurrence and outcome of APAP-induced liver injury in an obese individual with NAFLD would depend on a delicate balance between metabolic factors that augment the generation of NAPQI and others that can mitigate hepatotoxicity.<\/jats:p>","DOI":"10.3390\/livers3010003","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T05:45:33Z","timestamp":1673502333000},"page":"33-53","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Acetaminophen-Induced Hepatotoxicity in Obesity and Nonalcoholic Fatty Liver Disease: A Critical Review"],"prefix":"10.3390","volume":"3","author":[{"given":"Karima","family":"Begriche","sequence":"first","affiliation":[{"name":"INSERM, Univ Rennes, INRAE, Institut NUMECAN (Nutrition Metabolisms and Cancer) UMR_A 1341, UMR_S 1241, F-35000 Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Penhoat","sequence":"additional","affiliation":[{"name":"INSERM, Univ Rennes, INRAE, Institut NUMECAN (Nutrition Metabolisms and Cancer) UMR_A 1341, UMR_S 1241, F-35000 Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9n\u00e9lope","family":"Bernabeu-Gentey","sequence":"additional","affiliation":[{"name":"INSERM, Univ Rennes, INRAE, Institut NUMECAN (Nutrition Metabolisms and Cancer) UMR_A 1341, UMR_S 1241, F-35000 Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8213-5459","authenticated-orcid":false,"given":"Julie","family":"Massart","sequence":"additional","affiliation":[{"name":"INSERM, Univ Rennes, INRAE, Institut NUMECAN (Nutrition Metabolisms and Cancer) UMR_A 1341, UMR_S 1241, F-35000 Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Fromenty","sequence":"additional","affiliation":[{"name":"INSERM, Univ Rennes, INRAE, Institut NUMECAN (Nutrition Metabolisms and Cancer) UMR_A 1341, UMR_S 1241, F-35000 Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Barrett, L.A., Xing, A., Sheffler, J., Steidley, E., Adam, T.J., Zhang, R., and He, Z. (2022). Assessing the Use of Prescription Drugs and Dietary Supplements in Obese Respondents in the National Health and Nutrition Examination Survey. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0269241"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e12497","DOI":"10.1111\/cob.12497","article-title":"Pharmacotherapy of Obesity in Complex Diseases","volume":"12","author":"Pulipati","year":"2022","journal-title":"Clin. Obes."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/a-1877-9656","article-title":"Nonalcoholic Steatohepatitis Drug Development Pipeline: An Update","volume":"42","author":"Chew","year":"2022","journal-title":"Semin. Liver Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"154925","DOI":"10.1016\/j.metabol.2021.154925","article-title":"Insights into the Molecular Targets and Emerging Pharmacotherapeutic Interventions for Nonalcoholic Fatty Liver Disease","volume":"126","author":"Negi","year":"2022","journal-title":"Metabolism"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing Inappropriate Polypharmacy: The Process of Deprescribing","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.yrtph.2015.05.004","article-title":"Comedications Alter Drug-Induced Liver Injury Reporting Frequency: Data Mining in the WHO VigiBaseTM","volume":"72","author":"Suzuki","year":"2015","journal-title":"Regul. Toxicol. Pharm."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1016\/j.cgh.2018.12.013","article-title":"Patients With Chronic Liver Disease Suggestive of Nonalcoholic Fatty Liver Disease May Be at Higher Risk for Drug-Induced Liver Injury","volume":"17","author":"Lammert","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.cgh.2021.06.023","article-title":"Nonalcoholic Fatty Liver Disease for the Incidence of Drug-Induced Liver Injury","volume":"20","author":"Hwang","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1111\/liv.12514","article-title":"Acetaminophen-Induced Liver Injury in Obesity and Nonalcoholic Fatty Liver Disease","volume":"34","author":"Michaut","year":"2014","journal-title":"Liver Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"101470","DOI":"10.1016\/j.clinre.2020.05.018","article-title":"Cytochrome P450 2E1 Should Not Be Neglected for Acetaminophen-Induced Liver Injury in Metabolic Diseases with Altered Insulin Levels or Glucose Homeostasis","volume":"45","author":"Massart","year":"2021","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/gm493","article-title":"Serum Acute Phase Reactants Hallmark Healthy Individuals at Risk for Acetaminophen-Induced Liver Injury","volume":"5","author":"Borlak","year":"2013","journal-title":"Genome Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/hep.31678","article-title":"Acute Liver Injury With Therapeutic Doses of Acetaminophen: A Prospective Study","volume":"73","author":"Louvet","year":"2021","journal-title":"Hepatology"},{"key":"ref_13","first-page":"212","article-title":"Role of Nonalcoholic Fatty Liver Disease as Risk Factor for Drug-Induced Hepatotoxicity","volume":"3","author":"Massart","year":"2017","journal-title":"J. Clin. Transl. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"828565","DOI":"10.3389\/fphar.2022.828565","article-title":"N-Acetylcysteine for Preventing Acetaminophen-Induced Liver Injury: A Comprehensive Review","volume":"13","author":"Licata","year":"2022","journal-title":"Front. Pharm."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/hep.20948","article-title":"Acetaminophen-Induced Acute Liver Failure: Results of a United States Multicenter, Prospective Study","volume":"42","author":"Larson","year":"2005","journal-title":"Hepatology"},{"key":"ref_16","first-page":"131","article-title":"Acetaminophen-Induced Hepatotoxicity: A Comprehensive Update","volume":"4","author":"Yoon","year":"2016","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"111282","DOI":"10.1016\/j.fct.2020.111282","article-title":"A Mitochondrial Journey through Acetaminophen Hepatotoxicity","volume":"140","author":"Ramachandran","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0399-8320(04)95062-2","article-title":"Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs","volume":"28","author":"Biour","year":"2004","journal-title":"Gastroenterol. Clin. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/j.1365-2036.2007.03503.x","article-title":"Toxicity of Chronic Paracetamol Ingestion","volume":"26","author":"Watelet","year":"2007","journal-title":"Aliment. Pharm."},{"key":"ref_20","first-page":"1","article-title":"Acetaminophen Toxicity at Therapeutic Doses","volume":"3","author":"Yaghi","year":"2017","journal-title":"Intern. Med. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/03602532.2020.1832112","article-title":"The Development and Hepatotoxicity of Acetaminophen: Reviewing over a Century of Progress","volume":"52","author":"McGill","year":"2020","journal-title":"Drug Metab. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/livers2030008","article-title":"Acetaminophen Hepatotoxicity: Not as Simple as One Might Think! Introductory Comments on the Special Issue-Recent Advances in Acetaminophen Hepatotoxicity","volume":"2","author":"Jaeschke","year":"2022","journal-title":"Livers"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jhep.2021.06.021","article-title":"Advanced Preclinical Models for Evaluation of Drug-Induced Liver Injury\u2013Consensus Statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET]","volume":"75","author":"Bagnaninchi","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.tiv.2010.11.019","article-title":"Mitochondrial CYP2E1 Is Sufficient to Mediate Oxidative Stress and Cytotoxicity Induced by Ethanol and Acetaminophen","volume":"25","author":"Knockaert","year":"2011","journal-title":"Toxicol. Vitr."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Massart, J., Begriche, K., Hartman, J.H., and Fromenty, B. (2022). Role of Mitochondrial Cytochrome P450 2E1 in Healthy and Diseased Liver. Cells, 11.","DOI":"10.3390\/cells11020288"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1592\/phco.20.3.229.34774","article-title":"Phenytoin as a Possible Cause of Acetaminophen Hepatotoxicity: Case Report and Review of the Literature","volume":"20","author":"Brackett","year":"2000","journal-title":"Pharmacotherapy"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1007\/s11095-013-1007-6","article-title":"Metabolism and Disposition of Acetaminophen: Recent Advances in Relation to Hepatotoxicity and Diagnosis","volume":"30","author":"McGill","year":"2013","journal-title":"Pharm. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00228-017-2356-6","article-title":"Are Some People at Increased Risk of Paracetamol-Induced Liver Injury? A Critical Review of the Literature","volume":"74","author":"Caparrotta","year":"2018","journal-title":"Eur. J. Clin. Pharm."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.clinthera.2020.02.003","article-title":"Risk Factors for Acetaminophen-Induced Liver Injury: A Single-Center Study from Japan","volume":"42","author":"Hidaka","year":"2020","journal-title":"Clin. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1293\/tox.2018-0009","article-title":"Effects of Food Restriction on the Expression of Genes Related to Acetaminophen-Induced Liver Toxicity in Rats","volume":"31","author":"Tsuchiya","year":"2018","journal-title":"J. Toxicol. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1124\/jpet.112.202010","article-title":"Acute Liver Failure Study Group The UDP-Glucuronosyltransferase (UGT) 1A Polymorphism c.2042C>G (Rs8330) Is Associated with Increased Human Liver Acetaminophen Glucuronidation, Increased UGT1A Exon 5a\/5b Splice Variant MRNA Ratio, and Decreased Risk of Unintentional Acetaminophen-Induced Acute Liver Failure","volume":"345","author":"Court","year":"2013","journal-title":"J. Pharm. Exp."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/apt.17158","article-title":"Review Article: The Epidemiologic Burden of Non-Alcoholic Fatty Liver Disease across the World","volume":"56","author":"Henry","year":"2022","journal-title":"Aliment. Pharm."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/hep.31599","article-title":"American Association for the Study of Liver Diseases NASH Task Force NAFLD: Reporting Histologic Findings in Clinical Practice","volume":"73","author":"Brunt","year":"2021","journal-title":"Hepatology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2147\/JHC.S344559","article-title":"Hepatocellular Carcinoma Due to Nonalcoholic Fatty Liver Disease: Current Concepts and Future Challenges","volume":"9","author":"Ahmad","year":"2022","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.anndiagpath.2018.09.009","article-title":"Nonalcoholic Fatty Liver Disease (NAFLD): Diagnosis, Pitfalls, and Staging","volume":"37","author":"Koch","year":"2018","journal-title":"Ann. Diagn. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jhep.2010.11.021","article-title":"Presence and Significance of Microvesicular Steatosis in Nonalcoholic Fatty Liver Disease","volume":"55","author":"Tandra","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.26226","article-title":"Mitochondrial Adaptations and Dysfunctions in Nonalcoholic Fatty Liver Disease","volume":"58","author":"Begriche","year":"2013","journal-title":"Hepatology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tem.2016.11.006","article-title":"Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies","volume":"28","author":"Sunny","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"101122","DOI":"10.1016\/j.molmet.2020.101122","article-title":"Nonalcoholic Fatty Liver Disease (NAFLD) from Pathogenesis to Treatment Concepts in Humans","volume":"50","author":"Pafili","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/hep.22536","article-title":"Hepatitis C Is a Predictor of Acute Liver Injury among Hospitalizations for Acetaminophen Overdose in the United States: A Nationwide Analysis","volume":"48","author":"Nguyen","year":"2008","journal-title":"Hepatology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/hep.22798","article-title":"Hepatitis C, Alcohol Abuse, and Unintentional Overdoses Are Risk Factors for Acetaminophen-Related Hepatotoxicity","volume":"49","author":"Myers","year":"2009","journal-title":"Hepatology"},{"key":"ref_42","first-page":"19","article-title":"Being Overweight or Obese as a Risk Factor for Acute Liver Injury Secondary to Acute Acetaminophen Overdose","volume":"27","author":"Chomchai","year":"2018","journal-title":"Pharm. Drug Saf."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s40262-015-0357-0","article-title":"Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen","volume":"55","author":"Peeters","year":"2016","journal-title":"Clin. Pharm."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.cgh.2006.07.014","article-title":"Acute Liver Failure Study Group Influence of High Body Mass Index on Outcome in Acute Liver Failure","volume":"4","author":"Rutherford","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e714","DOI":"10.1097\/01.mjt.0000434043.62372.00","article-title":"Hepatotoxicity in Obese Versus Nonobese Patients With Acetaminophen Poisoning Who Are Treated With Intravenous N-Acetylcysteine","volume":"23","author":"Radosevich","year":"2016","journal-title":"Am. J. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/bs.apha.2019.01.003","article-title":"Drug-Induced Liver Injury in Obesity and Nonalcoholic Fatty Liver Disease","volume":"85","author":"Allard","year":"2019","journal-title":"Adv. Pharm."},{"key":"ref_47","first-page":"921","article-title":"Obesity as a Risk Factor in Drug-Induced Organ Injury: Increased Liver and Kidney Damage by Acetaminophen in the Obese Overfed Rat","volume":"241","author":"Corcoran","year":"1987","journal-title":"J. Pharm. Exp. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"G329","DOI":"10.1152\/ajpgi.00361.2009","article-title":"Diabetic KK-A(y) Mice Are Highly Susceptible to Oxidative Hepatocellular Damage Induced by Acetaminophen","volume":"299","author":"Kon","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1124\/jpet.112.193813","article-title":"Differences in Early Acetaminophen Hepatotoxicity between Obese Ob\/Ob and Db\/Db Mice","volume":"342","author":"Aubert","year":"2012","journal-title":"J. Pharm. Exp. Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1440-1746.2011.06807.x","article-title":"Susceptibility of Rat Non-Alcoholic Fatty Liver to the Acute Toxic Effect of Acetaminophen","volume":"27","author":"Podhola","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"16821","DOI":"10.1038\/s41598-019-53015-6","article-title":"PGC-1\u03b2 Induces Susceptibility To Acetaminophen-Driven Acute Liver Failure","volume":"9","author":"Piccinin","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2019.02.005","article-title":"Acetaminophen Aggravates Fat Accumulation in NAFLD by Inhibiting Autophagy via the AMPK\/MTOR Pathway","volume":"850","author":"Shi","year":"2019","journal-title":"Eur. J. Pharm."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"717276","DOI":"10.3389\/fphar.2021.717276","article-title":"Caveolin-1 Alleviates Acetaminophen-Induced Fat Accumulation in Non-Alcoholic Fatty Liver Disease by Enhancing Hepatic Antioxidant Ability via Activating AMPK Pathway","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharm."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/taap.1993.1240","article-title":"Acetaminophen Hepatotoxicity: Influence of Phenobarbital and Beta-Naphthoflavone Treatment in Obese and Lean Zucker Rats","volume":"123","author":"Tuntaterdtum","year":"1993","journal-title":"Toxicol. Appl. Pharm."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/10739680500383423","article-title":"Dietary Steatotic Liver Attenuates Acetaminophen Hepatotoxicity in Mice","volume":"13","author":"Ito","year":"2006","journal-title":"Microcirculation"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Kim, T.H., Choi, D., Kim, J.Y., Lee, J.H., and Koo, S.-H. (2017). Fast Food Diet-Induced Non-Alcoholic Fatty Liver Disease Exerts Early Protective Effect against Acetaminophen Intoxication in Mice. BMC Gastroenterol., 17.","DOI":"10.1186\/s12876-017-0680-z"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Ghallab, A., Myllys, M., Friebel, A., Duda, J., Edlund, K., Halilbasic, E., Vucur, M., Hobloss, Z., Brackhagen, L., and Begher-Tibbe, B. (2021). Spatio-Temporal Multiscale Analysis of Western Diet-Fed Mice Reveals a Translationally Relevant Sequence of Events during NAFLD Progression. Cells, 10.","DOI":"10.3390\/cells10102516"},{"key":"ref_58","first-page":"270","article-title":"Phenobarbital induction and acetaminophen hepatotoxi-city: Resistance in the obese Zucker rodent","volume":"243","author":"Blouin","year":"1987","journal-title":"J. Pharm. Exp. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.taap.2008.02.031","article-title":"Nonalcoholic Steatohepatitic (NASH) Mice Are Protected from Higher Hepatotoxicity of Acetaminophen upon Induction of PPARalpha with Clofibrate","volume":"230","author":"Donthamsetty","year":"2008","journal-title":"Toxicol. Appl. Pharm."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.bbadis.2018.06.023","article-title":"Animal Models of NAFLD from a Hepatologist\u2019s Point of View","volume":"1865","author":"Jahn","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"nzab138","DOI":"10.1093\/cdn\/nzab138","article-title":"Considerations When Choosing High-Fat, High-Fructose, and High-Cholesterol Diets to Induce Experimental Nonalcoholic Fatty Liver Disease in Laboratory Animal Models","volume":"5","author":"Radhakrishnan","year":"2021","journal-title":"Curr. Dev. Nutr."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Carreres, L., Jilkova, Z.M., Vial, G., Marche, P.N., Decaens, T., and Lerat, H. (2021). Modeling Diet-Induced NAFLD and NASH in Rats: A Comprehensive Review. Biomedicines, 9.","DOI":"10.3390\/biomedicines9040378"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1053\/j.gastro.2003.09.019","article-title":"Binge Ethanol Exposure Increases Liver Injury in Obese Rats","volume":"125","author":"Cederbaum","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1194\/jlr.M001602","article-title":"FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa\/fa) obese rats","volume":"51","author":"Cipriani","year":"2010","journal-title":"J. Lipid Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1440-1746.1990.tb01626.x","article-title":"Effect of genetic obesity and experimental diabetes on hepatic microsomal mixed function oxidase activities","volume":"5","author":"Zaluzny","year":"1990","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2613.2011.00793.x","article-title":"Pathology of the Liver in Obese and Diabetic Ob\/Ob and Db\/Db Mice Fed a Standard or High-Calorie Diet","volume":"92","author":"Paradis","year":"2011","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/hep.20949","article-title":"Alcohol increases tumor necrosis factor alpha and decreases nuclear factor-kB to activate hepatic apoptosis in genetically obese mice","volume":"42","author":"Robin","year":"2005","journal-title":"Hepatology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1006\/bbrc.1999.0202","article-title":"Altered Expression of Hepatic CYP2E1 and CYP4A in Obese, Diabetic Ob\/Ob Mice, and Fa\/Fa Zucker Rats","volume":"255","author":"Enriquez","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.hepres.2006.07.009","article-title":"Exacerbation of dietary steatohepatitis and fibrosis in obese, diabetic KK-A(y) mice","volume":"36","author":"Okumura","year":"2006","journal-title":"Hepatol. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/ijc.25711","article-title":"High susceptibility to azoxymethane-induced colorectal carcinogenesis in obese KK-Ay mice","volume":"129","author":"Teraoka","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/0006-2952(92)90530-V","article-title":"Effect of Dietary Fat on the in Vitro Hepatotoxicity of Paracetamol","volume":"44","author":"McDanell","year":"1992","journal-title":"Biochem. Pharm."},{"key":"ref_72","first-page":"S93","article-title":"Steatotic Rat Hepatocytes in Primary Culture Are More Susceptible to the Acute Toxic Effect of Acetaminophen","volume":"61","author":"Rychtrmoc","year":"2012","journal-title":"Physiol. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1002\/fsn3.1641","article-title":"Effects of Medium- and Long-Chain Fatty Acids on Acetaminophen- or Rifampicin-Induced Hepatocellular Injury","volume":"8","author":"Yang","year":"2020","journal-title":"Food Sci. Nutr."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.taap.2015.12.020","article-title":"A Cellular Model to Study Drug-Induced Liver Injury in Nonalcoholic Fatty Liver Disease: Application to Acetaminophen","volume":"292","author":"Michaut","year":"2016","journal-title":"Toxicol. Appl. Pharm."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"G298","DOI":"10.1152\/ajpgi.00458.2020","article-title":"Repetitive Amiodarone Administration Causes Liver Damage via Adipose Tissue ER Stress-Dependent Lipolysis, Leading to Hepatotoxic Free Fatty Acid Accumulation","volume":"321","author":"Hubel","year":"2021","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Mathur, M., Yeh, Y.-T., Arya, R.K., Jiang, L., Pornour, M., Chen, W., Ma, Y., Gao, B., He, L., and Ying, Z. (2022). Adipose Lipolysis Is Important for Ethanol to Induce Fatty Liver in the National Institute on Alcohol Abuse and Alcoholism Murine Model of Chronic and Binge Ethanol Feeding. Hepatology.","DOI":"10.1002\/hep.32675"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2131\/jts.43.423","article-title":"A 13-Week Subchronic Toxicity Study of Acetaminophen Using an Obese Rat Model","volume":"43","author":"Toyoda","year":"2018","journal-title":"J. Toxicol. Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2131\/jts.45.245","article-title":"Enhancement of Acetaminophen-Induced Chronic Hepatotoxicity in Spontaneously Diabetic Torii (SDT) Rats","volume":"45","author":"Kondo","year":"2020","journal-title":"J. Toxicol. Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.dld.2020.05.034","article-title":"Increased Risk of Acute Liver Failure by Pain Killer Drugs in NAFLD: Focus on Nuclear Receptors and Their Coactivators","volume":"53","author":"Arconzo","year":"2021","journal-title":"Dig. Liver Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2003.50095","article-title":"Hepatic Cytochrome P450 2E1 Activity in Nondiabetic Patients with Nonalcoholic Steatohepatitis","volume":"37","author":"Chalasani","year":"2003","journal-title":"Hepatology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.1478-3231.2007.01524.x","article-title":"Expression and Activity of the Cytochrome P450 2E1 in Patients with Nonalcoholic Steatosis and Steatohepatitis","volume":"27","author":"Chtioui","year":"2007","journal-title":"Liver Int."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.clinre.2011.04.015","article-title":"Increased Expression of Cytochrome P450 2E1 in Nonalcoholic Fatty Liver Disease: Mechanisms and Pathophysiological Role","volume":"35","author":"Aubert","year":"2011","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/11599410-000000000-00000","article-title":"Impact of Obesity on Drug Metabolism and Elimination in Adults and Children","volume":"51","author":"Brill","year":"2012","journal-title":"Clin. Pharm."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.yexmp.2015.11.008","article-title":"Induction of CYP2E1 in Non-Alcoholic Fatty Liver Diseases","volume":"99","author":"Aljomah","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/bcp.13602","article-title":"Higher Chlorzoxazone Clearance in Obese Children Compared with Nonobese Peers","volume":"84","author":"Gade","year":"2018","journal-title":"Br. J. Clin. Pharm."},{"key":"ref_86","first-page":"275","article-title":"Induction of Cytochrome P450IIE1 in the Obese Overfed Rat","volume":"39","author":"Raucy","year":"1991","journal-title":"Mol. Pharm."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"G27","DOI":"10.1152\/ajpgi.00296.2007","article-title":"A New Model for Nonalcoholic Steatohepatitis in the Rat Utilizing Total Enteral Nutrition to Overfeed a High-Polyunsaturated Fat Diet","volume":"294","author":"Baumgardner","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"E939","DOI":"10.1152\/ajpendo.00379.2007","article-title":"Partial Leptin Deficiency Favors Diet-Induced Obesity and Related Metabolic Disorders in Mice","volume":"294","author":"Begriche","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jhep.2012.05.019","article-title":"Critical Role of Cytochrome P450 2E1 (CYP2E1) in the Development of High Fat-Induced Non-Alcoholic Steatohepatitis","volume":"57","author":"Abdelmegeed","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1021\/acs.jafc.5b06159","article-title":"Ginger Essential Oil Ameliorates Hepatic Injury and Lipid Accumulation in High Fat Diet-Induced Nonalcoholic Fatty Liver Disease","volume":"64","author":"Lai","year":"2016","journal-title":"J. Agric. Food Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"115382","DOI":"10.1016\/j.jep.2022.115382","article-title":"Network Pharmacology Analysis on Mechanism of Jian Pi Qing Gan Yin Decoction Ameliorating High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease and Validated in Vivo","volume":"295","author":"Liu","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1124\/jpet.114.218131","article-title":"M1 Polarization Bias and Subsequent Nonalcoholic Steatohepatitis Progression Is Attenuated by Nitric Oxide Donor DETA NONOate via Inhibition of CYP2E1-Induced Oxidative Stress in Obese Mice","volume":"352","author":"Seth","year":"2015","journal-title":"J. Pharm. Exp. Ther."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Correia, M.A., and Kwon, D. (2020). Why Hepatic CYP2E1-Elevation by Itself Is Insufficient for Inciting NAFLD\/NASH: Inferences from Two Genetic Knockout Mouse Models. Biology, 9.","DOI":"10.3390\/biology9120419"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI8814","article-title":"CYP2E1 and CYP4A as Microsomal Catalysts of Lipid Peroxides in Murine Nonalcoholic Steatohepatitis","volume":"105","author":"Leclercq","year":"2000","journal-title":"J. Clin. Investig."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"39764","DOI":"10.1038\/srep39764","article-title":"Cytochrome P450-2E1 Promotes Fast Food-Mediated Hepatic Fibrosis","volume":"7","author":"Abdelmegeed","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jhep.2012.08.018","article-title":"CYP2E1 and Oxidant Stress in Alcoholic and Non-Alcoholic Fatty Liver Disease","volume":"58","author":"Leung","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"111326","DOI":"10.1016\/j.biopha.2021.111326","article-title":"New Insight and Potential Therapy for NAFLD: CYP2E1 and Flavonoids","volume":"137","author":"Wang","year":"2021","journal-title":"Biomed. Pharm."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/toxsci\/kfh126","article-title":"Regulation of CYP2E1 by Ethanol and Palmitic Acid and CYP4A11 by Clofibrate in Primary Cultures of Human Hepatocytes","volume":"79","author":"Raucy","year":"2004","journal-title":"Toxicol. Sci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"152579","DOI":"10.1016\/j.tox.2020.152579","article-title":"Dual TBK1\/IKK\u03b5 Inhibitor Amlexanox Mitigates Palmitic Acid-Induced Hepatotoxicity and Lipoapoptosis in Vitro","volume":"444","author":"Zhou","year":"2020","journal-title":"Toxicology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/FTD.0000000000000993","article-title":"Short-Term High-Fat Diet Alters Acetaminophen Metabolism in Healthy Individuals","volume":"44","author":"Achterbergh","year":"2022","journal-title":"Ther. Drug Monit."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/CS20030285","article-title":"Oxidative Stress-Related Parameters in the Liver of Non-Alcoholic Fatty Liver Disease Patients","volume":"106","author":"Videla","year":"2004","journal-title":"Clin. Sci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1124\/dmd.110.035006","article-title":"Diversity in Antioxidant Response Enzymes in Progressive Stages of Human Nonalcoholic Fatty Liver Disease","volume":"38","author":"Hardwick","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3892\/etm.2013.1434","article-title":"Effects of Glutamine on Oxidative Stress and Nuclear Factor-\u039aB Expression in the Livers of Rats with Nonalcoholic Fatty Liver Disease","volume":"7","author":"Lin","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e22696","DOI":"10.1002\/jbt.22696","article-title":"The Protective Effects of Trelagliptin on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Mice","volume":"35","author":"Wang","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.freeradbiomed.2016.03.032","article-title":"A Western Diet Induced NAFLD in LDLR(-\/)(-) Mice Is Associated with Reduced Hepatic Glutathione Synthesis","volume":"96","author":"Li","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Sta\u0148kov\u00e1, P., Ku\u010dera, O., Peterov\u00e1, E., Lotkov\u00e1, H., Maseko, T.E., No\u017ei\u010dkov\u00e1, K., and \u010cervinkov\u00e1, Z. (2020). Adaptation of Mitochondrial Substrate Flux in a Mouse Model of Nonalcoholic Fatty Liver Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21031101"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/livers2010003","article-title":"Oxidative Stress in Non-Alcoholic Fatty Liver Disease","volume":"2","author":"Smirne","year":"2022","journal-title":"Livers"},{"key":"ref_108","first-page":"S0168","article-title":"Mitochondrial Alterations in Fatty Liver Diseases","volume":"Oct 7. 22","author":"Fromenty","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"8096847","DOI":"10.1155\/2020\/8096847","article-title":"Gender Difference on the Effect of Omega-3 Polyunsaturated Fatty Acids on Acetaminophen-Induced Acute Liver Failure","volume":"2020","author":"Liu","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3892\/ijmm.2021.5023","article-title":"Omega-3 Polyunsaturated Fatty Acids Inhibit IL-11\/STAT3 Signaling in Hepatocytes during Acetaminophen Hepatotoxicity","volume":"48","author":"Liu","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jhep.2017.05.020","article-title":"Free Cholesterol Accumulation in Liver Sinusoidal Endothelial Cells Exacerbates Acetaminophen Hepatotoxicity via TLR9 Signaling","volume":"67","author":"Teratani","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cmet.2006.07.006","article-title":"Mitochondrial Free Cholesterol Loading Sensitizes to TNF- and Fas-Mediated Steatohepatitis","volume":"4","author":"Caballero","year":"2006","journal-title":"Cell Metab."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fphar.2014.00151","article-title":"Glutathione and Mitochondria","volume":"5","author":"Ribas","year":"2014","journal-title":"Front Pharm."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2022.05.009","article-title":"Hypercholesterolemia Reduces the Expression and Function of Hepatic Drug Metabolizing Enzymes and Transporters in Rats","volume":"364","author":"Xu","year":"2022","journal-title":"Toxicol. Lett."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e13622","DOI":"10.1111\/eci.13622","article-title":"Mitochondria, Oxidative Stress and Nonalcoholic Fatty Liver Disease: A Complex Relationship","volume":"52","author":"Simoes","year":"2022","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.1840380426","article-title":"Defective Hepatic Mitochondrial Respiratory Chain in Patients with Nonalcoholic Steatohepatitis","volume":"38","author":"Rubio","year":"2003","journal-title":"Hepatology"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of Hepatic Mitochondrial Function in Humans with Non-Alcoholic Fatty Liver Is Lost in Steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0003-9861(89)90504-3","article-title":"In Vitro Effects of Acetaminophen Metabolites and Analogs on the Respiration of Mouse Liver Mitochondria","volume":"273","author":"Ramsay","year":"1989","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/bcpt.13304","article-title":"Acetaminophen Toxicity Induces Mitochondrial Complex I Inhibition in Human Liver Tissue","volume":"126","author":"Larsen","year":"2020","journal-title":"Basic Clin. Pharm. Toxicol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"110916","DOI":"10.1016\/j.fct.2019.110916","article-title":"Alteration of Mitochondrial DNA Homeostasis in Drug-Induced Liver Injury","volume":"135","author":"Fromenty","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/hep.30333","article-title":"Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis","volume":"69","author":"Farrell","year":"2019","journal-title":"Hepatology"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and Resolution of Inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The Role of Macrophages in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jcmgh.2020.11.002","article-title":"Intestinal Dysbiosis Amplifies Acetaminophen-Induced Acute Liver Injury","volume":"11","author":"Schneider","year":"2021","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.it.2017.01.001","article-title":"NLRP6: A Multifaceted Innate Immune Sensor","volume":"38","author":"Levy","year":"2017","journal-title":"Trends Immunol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut Microbiota and Human NAFLD: Disentangling Microbial Signatures from Metabolic Disorders","volume":"17","author":"Vigliotti","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Breton, J., Galmiche, M., and D\u00e9chelotte, P. (2022). Dysbiotic Gut Bacteria in Obesity: An Overview of the Metabolic Mechanisms and Therapeutic Perspectives of Next-Generation Probiotics. Microorganisms, 10.","DOI":"10.3390\/microorganisms10020452"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/taap.1997.8115","article-title":"Bacterial Endotoxin Enhances the Hepatotoxicity of Allyl Alcohol","volume":"144","author":"Sneed","year":"1997","journal-title":"Toxicol. Appl. Pharm."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/toxsci\/kfq168","article-title":"Idiosyncratic Drug-Induced Liver Injury and the Role of Inflammatory Stress with an Emphasis on an Animal Model of Trovafloxacin Hepatotoxicity","volume":"118","author":"Shaw","year":"2010","journal-title":"Toxicol. Sci."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Wu, W., Zhao, L., Yang, P., Zhou, W., Li, B., Moorhead, J.F., Varghese, Z., Ruan, X.Z., and Chen, Y. (2016). Inflammatory Stress Sensitizes the Liver to Atorvastatin-Induced Injury in ApoE-\/- Mice. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0159512"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/j.1552-4604.1981.tb01768.x","article-title":"The Effect of Obesity on Acetaminophen Pharmacokinetics in Man","volume":"21","author":"Lee","year":"1981","journal-title":"J. Clin. Pharm."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/clpt.1982.111","article-title":"Obesity, Sex, and Acetaminophen Disposition","volume":"31","author":"Abernethy","year":"1982","journal-title":"Clin. Pharm. Ther."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/jhep.2003.50342","article-title":"CYP2E1 Activity before and after Weight Loss in Morbidly Obese Subjects with Nonalcoholic Fatty Liver Disease","volume":"38","author":"Emery","year":"2003","journal-title":"Hepatology"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/bbrc.2000.2125","article-title":"Constitutive and Inducible Expression of Hepatic CYP2E1 in Leptin-Deficient Ob\/Ob Mice","volume":"268","author":"Leclercq","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_135","first-page":"707","article-title":"Cytokines Down-Regulate Expression of Major Cytochrome P-450 Enzymes in Adult Human Hepatocytes in Primary Culture","volume":"44","author":"Loyer","year":"1993","journal-title":"Mol. Pharm."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.bcp.2010.08.005","article-title":"IL-4-Mediated Transcriptional Regulation of Human CYP2E1 by Two Independent Signaling Pathways","volume":"80","author":"Wang","year":"2010","journal-title":"Biochem. Pharm."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Lin, Q., Kang, X., Li, X., Wang, T., Liu, F., Jia, J., Jin, Z., and Xue, Y. (2019). NF-\u039aB-Mediated Regulation of Rat CYP2E1 by Two Independent Signaling Pathways. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0225531"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Drozdzik, M., Lapczuk-Romanska, J., Wenzel, C., Szelag-Pieniek, S., Post, M., Skalski, \u0141., Kurzawski, M., and Oswald, S. (2021). Gene Expression and Protein Abundance of Hepatic Drug Metabolizing Enzymes in Liver Pathology. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13091334"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1124\/dmd.107.020073","article-title":"Decreased Expression of Cytochromes P450 1A2, 2E1, and 3A4 and Drug Transporters Na+-Taurocholate-Cotransporting Polypeptide, Organic Cation Transporter 1, and Organic Anion-Transporting Peptide-C Correlates with the Progression of Liver Fibrosis in Chronic Hepatitis C Patients","volume":"36","author":"Nakai","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s002040050667","article-title":"Effect of Transforming Growth Factor-Beta1 on Cytochrome P450 Expression: Inhibition of CYP1 MRNA and Protein Expression in Primary Rat Hepatocytes","volume":"74","author":"Kahl","year":"2000","journal-title":"Arch. Toxicol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jhep.2009.12.003","article-title":"TGF-Beta Enhances Alcohol Dependent Hepatocyte Damage via down-Regulation of Alcohol Dehydrogenase I","volume":"52","author":"Ciuclan","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.cgh.2006.12.021","article-title":"Association between Nonalcoholic Hepatic Steatosis and Hepatic Cytochrome P-450 3A Activity","volume":"5","author":"Kolwankar","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/jphp.12646","article-title":"Diet-Induced Non-Alcoholic Fatty Liver Disease Affects Expression of Major Cytochrome P450 Genes in a Mouse Model","volume":"68","author":"Chiba","year":"2016","journal-title":"J. Pharm. Pharm."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1124\/dmd.115.065979","article-title":"CYP3A Activity and Expression in Nonalcoholic Fatty Liver Disease","volume":"43","author":"Woolsey","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-Alcoholic Fatty Liver Disease (NAFLD)\u2014Pathogenesis, Classification, and Effect on Drug Metabolizing Enzymes and Transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab. Rev."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1021\/acs.molpharmaceut.8b00159","article-title":"Nonalcoholic Fatty Liver Disease and Diabetes Are Associated with Decreased CYP3A4 Protein Expression and Activity in Human Liver","volume":"15","author":"Jamwal","year":"2018","journal-title":"Mol. Pharm."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/17425255.2018.1440287","article-title":"Obesity and Drug Pharmacology: A Review of the Influence of Obesity on Pharmacokinetic and Pharmacodynamic Parameters","volume":"14","author":"Smit","year":"2018","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cbi.2019.05.038","article-title":"CYP3A Suppression during Diet-Induced Nonalcoholic Fatty Liver Disease Is Independent of PXR Regulation","volume":"308","author":"Zeng","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.xphs.2020.10.027","article-title":"Correlation of Body Weight and Composition With Hepatic Activities of Cytochrome P450 Enzymes","volume":"110","author":"Krogstad","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"120133","DOI":"10.1016\/j.lfs.2021.120133","article-title":"Hepatic Cytochrome P450 Function Is Reduced by Life-Long Western Diet Consumption in Guinea Pig Independent of Birth Weight","volume":"287","author":"Wiese","year":"2021","journal-title":"Life Sci."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1124\/dmd.109.027466","article-title":"Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease","volume":"37","author":"Fisher","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1124\/dmd.111.040592","article-title":"Analysis of Global and Absorption, Distribution, Metabolism, and Elimination Gene Expression in the Progressive Stages of Human Nonalcoholic Fatty Liver Disease","volume":"39","author":"Lake","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"e21840","DOI":"10.1002\/jbt.21840","article-title":"In Vivo Cytochrome P450 Activity Alterations in Diabetic Nonalcoholic Steatohepatitis Mice","volume":"31","author":"Li","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3727\/105221618X15341831737687","article-title":"Bioinformatics Analysis of Key Differentially Expressed Genes in Nonalcoholic Fatty Liver Disease Mice Models","volume":"19","author":"Hou","year":"2018","journal-title":"Gene Expr."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Gabbia, D., Roverso, M., Guido, M., Sacchi, D., Scaffidi, M., Carrara, M., Orso, G., Russo, F.P., Floreani, A., and Bogialli, S. (2019). Western Diet-Induced Metabolic Alterations Affect Circulating Markers of Liver Function before the Development of Steatosis. Nutrients, 11.","DOI":"10.3390\/nu11071602"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.xphs.2019.11.007","article-title":"Dietary-Induced Obesity, Hepatic Cytochrome P450, and Lidocaine Metabolism: Comparative Effects of High-Fat Diets in Mice and Rats and Reversibility of Effects With Normalization of Diet","volume":"109","author":"Ussher","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41401-022-00924-4","article-title":"Silybin Regulates P450s Activity by Attenuating Endoplasmic Reticulum Stress in Mouse Nonalcoholic Fatty Liver Disease","volume":"44","author":"Wu","year":"2022","journal-title":"Acta Pharm. Sin."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.gendis.2021.02.008","article-title":"Comparison of Hepatic Gene Expression Profiles between Three Mouse Models of Nonalcoholic Fatty Liver Disease","volume":"9","author":"Xiang","year":"2022","journal-title":"Genes Dis."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.taap.2014.06.019","article-title":"Evaluation of Aroclor 1260 Exposure in a Mouse Model of Diet-Induced Obesity and Non-Alcoholic Fatty Liver Disease","volume":"279","author":"Wahlang","year":"2014","journal-title":"Toxicol. Appl. Pharm."},{"key":"ref_160","first-page":"873","article-title":"Enhanced Glucuronide Conjugation of Drugs in Obesity: Studies of Lorazepam, Oxazepam, and Acetaminophen","volume":"101","author":"Abernethy","year":"1983","journal-title":"J. Lab. Clin. Med."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MPG.0b013e3181f9b3a0","article-title":"Acetaminophen Pharmacokinetics in Children with Nonalcoholic Fatty Liver Disease","volume":"52","author":"Barshop","year":"2011","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/FPC.0000000000000150","article-title":"PharmGKB Summary: Pathways of Acetaminophen Metabolism at the Therapeutic versus Toxic Doses","volume":"25","author":"Mazaleuskaya","year":"2015","journal-title":"Pharm. Genom."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1124\/dmd.112.048439","article-title":"Altered UDP-Glucuronosyltransferase and Sulfotransferase Expression and Function during Progressive Stages of Human Nonalcoholic Fatty Liver Disease","volume":"41","author":"Hardwick","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bcp.2018.04.019","article-title":"Acetaminophen-Induced Liver Injury Is Attenuated in Transgenic Fat-1 Mice Endogenously Synthesizing Long-Chain n-3 Fatty Acids","volume":"154","author":"Feng","year":"2018","journal-title":"Biochem. Pharm."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"108387","DOI":"10.1016\/j.abb.2020.108387","article-title":"Omega-3 Fatty Acids Protect against Acetaminophen-Induced Hepatic and Renal Toxicity in Rats through HO-1-Nrf2-BACH1 Pathway","volume":"687","author":"Eraky","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_166","first-page":"557","article-title":"Fish Oil Protects Mice against Acetaminophen Hepatotoxicity in Vivo","volume":"13","author":"Speck","year":"1991","journal-title":"Hepatology"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1004564","DOI":"10.3389\/fendo.2022.1004564","article-title":"Treatment with Omega-3 PUFAs Does Not Increase the Risk of CYP2E1-Dependent Oxidative Stress and Diabetic Liver Pathology","volume":"13","author":"Maksymchuk","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1038\/s41366-022-01217-w","article-title":"Use of Primary Bariatric Surgery among Patients with Obesity and Diabetes. Insights from the Diabetes Collaborative Registry","volume":"46","author":"Jain","year":"2022","journal-title":"Int. J. Obes."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1007\/s11695-022-06011-1","article-title":"Bariatric Surgery Improves Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis","volume":"32","author":"Zhou","year":"2022","journal-title":"Obes. Surg."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/MCG.0000000000000278","article-title":"Acute Liver Failure Due to Acetaminophen Poisoning in Patients With Prior Weight Loss Surgery: A Case Series","volume":"49","author":"Holt","year":"2015","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s11695-020-04999-y","article-title":"First Case Report of Fulminant Hepatitis After Laparoscopic Sleeve Gastrectomy Associated with Concomitant Maximal Therapeutic Dose of Acetaminophen Use, Protein Calorie Malnutrition, and Vitamins A and D, Selenium, and Glutathione Deficiencies","volume":"31","author":"Abusabeib","year":"2021","journal-title":"Obes. Surg."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/bcpt.13234","article-title":"Laparoscopic Roux-En-Y Gastric Bypass Surgery Influenced Pharmacokinetics of Several Drugs given as a Cocktail with the Highest Impact Observed for CYP1A2, CYP2C8 and CYP2E1 Substrates","volume":"125","author":"Puris","year":"2019","journal-title":"Basic. Clin. Pharm. Toxicol."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Porat, D., Markovic, M., Zur, M., Fine-Shamir, N., Azran, C., Shaked, G., Czeiger, D., Vaynshtein, J., Replyanski, I., and Sebbag, G. (2019). Increased Paracetamol Bioavailability after Sleeve Gastrectomy: A Crossover Pre- vs. Post-Operative Clinical Trial. J. Clin. Med., 8.","DOI":"10.3390\/jcm8111949"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/phar.2368","article-title":"The Impact of Proximal Roux-En-Y Gastric Bypass Surgery on Acetaminophen Absorption and Metabolism","volume":"40","author":"Chen","year":"2020","journal-title":"Pharmacotherapy"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1038\/nrdp.2017.16","article-title":"Type 1 Diabetes Mellitus","volume":"3","author":"Katsarou","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/postgradmedj-2015-133281","article-title":"Pathophysiology of Type 1 and Type 2 Diabetes Mellitus: A 90-Year Perspective","volume":"92","author":"Zaccardi","year":"2016","journal-title":"Postgrad. Med. J."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41574-020-0355-7","article-title":"Pancreatic \u03b2-Cells in Type 1 and Type 2 Diabetes Mellitus: Different Pathways to Failure","volume":"16","author":"Eizirik","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1210\/clinem\/dgaa575","article-title":"Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis","volume":"105","author":"Westerink","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"768576","DOI":"10.3389\/fphar.2021.768576","article-title":"Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-Alcoholic Fatty Liver Disease From Glycogenic Hepatopathy","volume":"12","author":"Mertens","year":"2021","journal-title":"Front. Pharm."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1053\/gast.2002.33650","article-title":"Diabetes Increases the Risk of Acute Hepatic Failure","volume":"122","author":"Everhart","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Drug Induced Liver Injury Network (DILIN) Causes, Clinical Features, and Outcomes from a Prospective Study of Drug-Induced Liver Injury in the United States","volume":"135","author":"Chalasani","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3892\/etm.2016.3627","article-title":"Clinical Characteristics of Drug-Induced Liver Injury and Related Risk Factors","volume":"12","author":"Lu","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1258\/la.2010.010090","article-title":"Single Dose Streptozotocin-Induced Diabetes: Considerations for Study Design in Islet Transplantation Models","volume":"45","author":"Deeds","year":"2011","journal-title":"Lab. Anim."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41420-019-0198-y","article-title":"Hyperglycemia Exacerbates Acetaminophen-Induced Acute Liver Injury by Promoting Liver-Resident Macrophage Proinflammatory Response via AMPK\/PI3K\/AKT-Mediated Oxidative Stress","volume":"5","author":"Wang","year":"2019","journal-title":"Cell Death Discov."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/abbi.1993.1196","article-title":"Combined Effects of Streptozotocin-Induced Diabetes plus 4-Methylpyrazole Treatment on Rat Liver Cytochrome P4502E1","volume":"302","author":"Wu","year":"1993","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2337\/diabetes.53.1.185","article-title":"Elevated Mitochondrial Cytochrome P450 2E1 and Glutathione S-Transferase A4-4 in Streptozotocin-Induced Diabetic Rats: Tissue-Specific Variations and Roles in Oxidative Stress","volume":"53","author":"Raza","year":"2004","journal-title":"Diabetes"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1080\/10715760600801272","article-title":"Differential Regulation of Hepatic Cytochrome P450 Monooxygenases in Streptozotocin-Induced Diabetic Rats","volume":"40","author":"Sindhu","year":"2006","journal-title":"Free Radic. Res."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.pharep.2017.05.020","article-title":"Quercetin Prevents Type 1 Diabetic Liver Damage through Inhibition of CYP2E1","volume":"69","author":"Maksymchuk","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"ref_189","first-page":"504","article-title":"Increased Resistance of Diabetic Rats to Acetaminophen-Induced Hepatotoxicity","volume":"220","author":"Price","year":"1982","journal-title":"J. Pharm. Exp. Ther."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/toxsci\/kfg059","article-title":"Type 1 Diabetic Mice Are Protected from Acetaminophen Hepatotoxicity","volume":"73","author":"Shankar","year":"2003","journal-title":"Toxicol. Sci."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1096\/fj.02-1186fje","article-title":"Activation of PPAR-Alpha in Streptozotocin-Induced Diabetes Is Essential for Resistance against Acetaminophen Toxicity","volume":"17","author":"Shankar","year":"2003","journal-title":"FASEB J."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jhep.2017.11.006","article-title":"The Bidirectional Impacts of Alcohol Consumption and the Metabolic Syndrome: Cofactors for Progressive Fatty Liver Disease","volume":"68","author":"Boyle","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Di Ciaula, A., Bonfrate, L., Krawczyk, M., Fr\u00fchbeck, G., and Portincasa, P. (2022). Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052636"},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Massart, J., Begriche, K., Corlu, A., and Fromenty, B. (2022). Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031062"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1080\/17425255.2020.1817896","article-title":"Novel strategies for the treatment of acetaminophen hepatotoxicity","volume":"16","author":"Akakpo","year":"2020","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Subramanya, S.B., Venkataraman, B., Meeran, M.F.N., Goyal, S.N., Patil, C.R., and Ojha, S. (2018). Therapeutic Potential of Plants and Plant Derived Phytochemicals against Acetaminophen-Induced Liver Injury. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19123776"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3727\/105221621X16104581979144","article-title":"Ferroptosis and Acetaminophen Hepatotoxicity: Are We Going Down Another Rabbit Hole?","volume":"20","author":"Jaeschke","year":"2021","journal-title":"Gene Expr."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"112917","DOI":"10.1016\/j.jep.2020.112917","article-title":"Oroxyloside ameliorates acetaminophen-induced hepatotoxicity by inhibiting JNK related apoptosis and necroptosis","volume":"258","author":"Liao","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Hwang, K.A., Hwang, Y., Hwang, H.J., and Park, N. (2022). Hepatoprotective Effects of Radish (Raphanus sativus L.) on Acetaminophen-Induced Liver Damage via Inhibiting Oxidative Stress and Apoptosis. Nutrients, 14.","DOI":"10.3390\/nu14235082"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.fct.2017.08.020","article-title":"Induction of mitochondrial biogenesis protects against acetaminophen hepatotoxicity","volume":"108","author":"Du","year":"2017","journal-title":"Food Chem. Toxicol."}],"container-title":["Livers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2673-4389\/3\/1\/3\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:04:17Z","timestamp":1760119457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2673-4389\/3\/1\/3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":200,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["livers3010003"],"URL":"https:\/\/doi.org\/10.3390\/livers3010003","relation":{},"ISSN":["2673-4389"],"issn-type":[{"value":"2673-4389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]}}}